8.02
+6.65%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Maravai LifeSciences Holdings
From its filings with the US Securities and Exchange Commission
Maravai LifeSciences Holdings is based in San Diego, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker MRVI. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $185.7m and a net loss of $130.8m. At that date it held total assets of $770.6m and shareholders' equity of $212.4m. By business, TriLink brought in 64.5% of revenue, followed by Cygnus at 35.5%.
Maravai LifeSciences Holdings, Inc. (also referred to in this document as “Maravai,” “we,” “us,” “our” or “the Company”) is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Our customers include biopharmaceutical companies, emerging biotech firms, life science research organizations, academic research institutions and diagnostics companies.
We operate and report our business in two segments – TriLink, formerly referred to as Nucleic Acid Production, and Cygnus, formerly referred to as Biologics Safety Testing.
During fiscal year 2025, we renamed our reportable segments from Nucleic Acid Production and Biologics Safety Testing to TriLink and Cygnus, respectively. This change reflects updated segment naming to better align with our internal brand and operating terminology. There were no changes to the composition of our reportable segments, the nature of the products and services offered, or the manner in which the chief operating decision maker (“CODM”) evaluates the Company’s operating performance or allocates resources.
Quoted from its 10-K, filed 26 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 20 Nov 2020
- Employees
- 435
- Website
- maravai.com ↗
- Head office
- 10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO, CA, 92121
- Incorporated in
- DE
- Classification
- Pharmaceutical Preparations
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Mr. Robert EckertIndependent Chairman of the Board$750,002
- Mr. Bernd BrustChief Executive Officer, Director, since 2025
- Mr. Rajesh AsarpotaChief Financial Officer
- Mr. Kurt OreshackExecutive Vice President, General Counsel, Secretary$701,398
- Ms. Christine DolanExecutive Vice President, General Manager - Cygnus Technologies$2.3m
- Mr. Sean CunninghamDirector$290,053
- Mr. Benjamin DavermanDirector$282,553
- Mr. Luke MarkerDirector$282,553
- Mr. Constantine MihasDirector$292,553
- Dr. John DefordIndependent Director$310,053
- Ms. Susannah GrayIndependent Director$317,553
- Dr. Jessica HopfieldIndependent Director$310,053
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 62
- Environment
- 66
- Social
- 99
- Governance
- 22
- Direct emissions (scope 1)
- 862.58 t
- Energy emissions (scope 2)
- 2,232.37 t
- Value chain emissions (scope 3)
- 73,216.27 t
- Women in the workforce
- 44.2%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Maravai LifeSciences Holdings Inc possesses several strengths that contribute to its competitive advantage:
- Maravai LifeSciences Holdings Inc faces certain weaknesses that could hinder its growth and performance:
- Maravai LifeSciences Holdings Inc can capitalize on the following opportunities in the market:
- Maravai LifeSciences Holdings Inc faces certain threats that could potentially impact its business negatively:
Weaknesses
- Maravai LifeSciences Holdings Inc faces certain weaknesses that could hinder its growth and performance:
- Maravai LifeSciences Holdings Inc can capitalize on the following opportunities in the market:
- Maravai LifeSciences Holdings Inc faces certain threats that could potentially impact its business negatively:
Opportunities
- Maravai LifeSciences Holdings Inc can capitalize on the following opportunities in the market:
- Maravai LifeSciences Holdings Inc faces certain threats that could potentially impact its business negatively:
Threats
- Maravai LifeSciences Holdings Inc faces certain threats that could potentially impact its business negatively:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.